Evidence map›Paper›PMID 30870159›Full record

Trial reportAnesthesiology2019

Intravenous Lidocaine Does Not Improve Neurologic Outcomes after Cardiac Surgery: A Randomized Controlled Trial.

Rebecca Y Klinger, Mary Cooter, Tiffany Bisanar, Niccolò Terrando, Miles Berger, Mihai V Podgoreanu, Mark Stafford-Smith, Mark F Newman, Joseph P Mathew, Neurologic Outcomes Research Group of the Duke Heart Center

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Anesthesiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 3 countries.

Rebecca Y KlingerFrom the Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina (R.Y.K., M.C., T.B., N.T., M.B., M.V.P., M.S.-S., J.P.M.) the Department of Anesthesiology, University of Kentucky School of Medicine, Lexington, Kentucky (M.F.N.).
Mary Cooter
Tiffany Bisanar
Niccolò Terrando
Miles Berger
Mihai V Podgoreanu
Mark Stafford-Smith
Mark F Newman
Joseph P Mathew
Neurologic Outcomes Research Group of the Duke Heart Center
University of Kentucky · US

Funding

Cognitive Effects of Body Temperature During Hypothermic Circulatory ArrestR01HL130443 · NHLBI · DUKE UNIVERSITY · PI HUGHES, G. CHAD, MATHEW, JOSEPH P · 2016 to 2020
$3.5M
Lidocaine for Neuroprotection During Cardiac SurgeryR01HL096978 · NHLBI · DUKE UNIVERSITY · PI MATHEW, JOSEPH P · 2009 to 2013
$1.8M
Cortical Beta-amyloid Levels and Neurocognitive Performance After Cardiac SurgeryR21HL108280 · NHLBI · DUKE UNIVERSITY · PI MATHEW, JOSEPH P · 2011 to 2012
$432k
Functional Connectivity Changes In Attention Networks after Cardiac SurgeryR21HL109971 · NHLBI · DUKE UNIVERSITY · PI BROWNDYKE, JEFFREY N, MATHEW, JOSEPH P · 2012 to 2013
$422k
NHLBI NIH HHS R01 HL096978NHLBI NIH HHS R01 HL130443NHLBI NIH HHS R21 HL108280NHLBI NIH HHS R21 HL109971
6 · The paper itself

Abstract

backgroundCognitive decline after cardiac surgery occurs frequently and persists in a significant proportion of patients. Preclinical studies and human trials suggest that intravenous lidocaine may confer protection in the setting of neurologic injury. It was hypothesized that lidocaine administration would reduce cognitive decline after cardiac surgery compared to placebo.

methodsAfter institutional review board approval, 478 patients undergoing cardiac surgery were enrolled into this multicenter, prospective, randomized, double-blinded, placebo-controlled, parallel group trial. Subjects were randomized to lidocaine 1 mg/kg bolus after the induction of anesthesia followed by a continuous infusion (48 μg · kg · min for the first hour, 24 μg · kg · min for the second hour, and 10 μg · kg · min for the next 46 h) or saline with identical volume and rate changes to preserve blinding. Cognitive function was assessed preoperatively and at 6 weeks and 1 yr postoperatively using a standard neurocognitive test battery. The primary outcome was change in cognitive function between baseline and 6 weeks postoperatively, adjusting for age, years of education, baseline cognition, race, and procedure type.

resultsAmong the 420 allocated subjects who returned for 6-week follow-up (lidocaine: N = 211; placebo: N = 209), there was no difference in the continuous cognitive score change (adjusted mean difference [95% CI], 0.02 (-0.05, 0.08); P = 0.626). Cognitive deficit (greater than 1 SD decline in at least one cognitive domain) at 6 weeks occurred in 41% (87 of 211) in the lidocaine group versus 40% (83 of 209) in the placebo group (adjusted odds ratio [95% CI], 0.94 [0.63, 1.41]; P = 0.766). There were no differences in any quality of life outcomes between treatment groups. At the 1-yr follow-up, there continued to be no difference in cognitive score change, cognitive deficit, or quality of life.

conclusionsIntravenous lidocaine administered during and after cardiac surgery did not reduce postoperative cognitive decline at 6 weeks.

Indexed as

Administration, IntravenousAgedAnesthetics, LocalCardiac Surgical ProceduresDouble-Blind MethodFemaleFollow-Up StudiesHumansLidocaineMaleMental Status and Dementia TestsMiddle AgedNeurocognitive DisordersPostoperative Cognitive ComplicationsProspective StudiesTreatment OutcomeAnesthetics, LocalLidocaine

Identifiers

PMID30870159
PMCPMC6520120
OpenAlexW2922527809

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.